BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients usually undergo surgery followed by aggressive radio- and chemotherapy with the alkylating agent temozolomide (TMZ). Still, median survival is only 12–15 months after diagnosis. Many human cancers incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Čančer, Matko, Drews, Lisa F., Bengtsson, Johan, Bolin, Sara, Rosén, Gabriela, Westermark, Bengt, Nelander, Sven, Forsberg-Nilsson, Karin, Uhrbom, Lene, Weishaupt, Holger, Swartling, Fredrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872649/
https://www.ncbi.nlm.nih.gov/pubmed/31754113
http://dx.doi.org/10.1038/s41419-019-2120-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872649/
https://www.ncbi.nlm.nih.gov/pubmed/31754113
http://dx.doi.org/10.1038/s41419-019-2120-1

Ejemplares similares